4.2 Article

Resting state functional connectivity patterns associated with pharmacological treatment resistance in temporal lobe epilepsy

Journal

EPILEPSY RESEARCH
Volume 149, Issue -, Pages 37-43

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eplepsyres.2018.11.002

Keywords

Epilepsy; Temporal lobe epilepsy; Biomarker; Treatment response; fMRI; Resting State fMRI

Funding

  1. UCB Pharma
  2. Eisai
  3. Pfizer
  4. Lundbeck
  5. Sunovion
  6. Andrews Foundation
  7. Vogelstein Foundation
  8. Finding A Cure for Epilepsy and Seizures (FACES)
  9. Friends of Faces
  10. Morris and Alma Schapiro Fund
  11. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [UL1 TR001866]

Ask authors/readers for more resources

There are no functional imaging based biomarkers for pharmacological treatment response in temporal lobe epilepsy (TLE). In this study, we investigated whether there is an association between resting state functional brain connectivity (RsFC) and seizure control in TLE. We screened a large database containing resting state functional magnetic resonance imaging (Rs-fMRI) data from 286 epilepsy patients. Patient medical records were screened for seizure characterization, EEG reports for lateralization and location of seizure foci to establish uniformity of seizure localization within patient groups. Rs-fMRI data from patients with well-controlled left TLE, patients with treatment-resistant left TLE, and healthy controls were analyzed. Healthy controls and cTLE showed similar functional connectivity patterns, whereas trTLE exhibited a significant bilateral decrease in thalamo-hippocampal functional connectivity. This work is the first to demonstrate differences in neural network connectivity between well-controlled and treatment-resistant TLE. These differences are spatially highly focused and suggest sites for the etiology and possibly treatment of TLE. Altered thalamo-hippocampal RsFC thus is a potential new biomarker for TLE treatment resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available